Chromosomal gain: from MGUS to MULTIPLE MYELOMA

被引：0
|
作者：
Martorana, L.
Azzena, A.
Murru, R.
Deidda, S.
Licheri, M.
Virdis, M.
Floris, R.
Orru, S.
Carcassi, C.
机构：
来源：
CHROMOSOME RESEARCH | 2009年 / 17卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
  • [31] Cytogenetic patterns in multiple myeloma after a phase of preceding MGUS
    Kaufmann, H.
    Ackermann, J.
    Odelga, V.
    Sagaster, V.
    Noesslinger, T.
    Pfeilstoecker, M.
    Keck, A.
    Ludwig, H.
    Gisslinger, H.
    Drach, J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (01) : 53 - 60
  • [32] MGUS: Comparison of patients who converted to multiple myeloma.
    Stanisic, S
    Saluan, MA
    McLain, D
    Cakulev, I
    Rybicki, L
    Hussein, MA
    BLOOD, 1998, 92 (10) : 271B - 271B
  • [33] The Progression from MGUS to Smoldering Myeloma and Eventually to Multiple Myeloma Involves a Clonal Expansion of Genetically Abnormal Plasma Cells
    Lopez-Corral, Lucia
    Gutierrez, Norma C.
    Belen Vidriales, Maria
    Victoria Mateos, Maria
    Rasillo, Ana
    Garcia-Sanz, Ramon
    Paiva, Bruno
    San Miguel, Jesus F.
    CLINICAL CANCER RESEARCH, 2011, 17 (07) : 1692 - 1700
  • [34] Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability
    Dutta, Ankit K.
    Fink, J. Lynn
    Grady, John P.
    Morgan, Gareth J.
    Mullighan, Charles G.
    To, Luen B.
    Hewett, Duncan R.
    Zannettino, Andrew C. W.
    LEUKEMIA, 2019, 33 (02) : 457 - 468
  • [35] Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability
    Ankit K. Dutta
    J. Lynn Fink
    John P. Grady
    Gareth J. Morgan
    Charles G. Mullighan
    Luen B. To
    Duncan R. Hewett
    Andrew C. W. Zannettino
    Leukemia, 2019, 33 : 457 - 468
  • [36] Multiple myeloma disguised as monoclonal gammopathy of undetermined significance? MGUS-like phenotype of a multiple myeloma subgroup
    Hammami, Emna
    HEMATOLOGIE, 2023, 29 (04): : 218 - 219
  • [37] Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma
    Steiner, Normann
    Goebel, Georg
    Michaeler, Daniela
    Platz, Anna-Luise
    Prokop, Wolfgang
    Wolf, Anna Maria
    Wolf, Dominik
    Duftner, Christina
    Gunsilius, Eberhard
    BLOOD ADVANCES, 2021, 5 (06) : 1746 - 1754
  • [38] Post-MGUS Diagnosis Serum M-Protein Velocity and the Risk of Progression of MGUS to Multiple Myeloma
    Chang, Su-Hsin
    Gumbel, Jason H.
    Thomas, Theodore S.
    Luo, Suhong
    Sanfilippo, Kristen M.
    Colditz, Graham A.
    Carson, Kenneth R.
    BLOOD, 2017, 130
  • [39] A gene signature can predict risk of MGUS progressing to multiple myeloma
    Sun, Fumou
    Cheng, Yan
    Ying, Jun
    Mery, David
    Al Hadidi, Samer
    Wanchai, Visanu
    Siegel, Eric R.
    Xu, Hongwei
    Gai, Dongzheng
    Ashby, Timothy Cody
    Bailey, Clyde
    Chen, Jin-Ran
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    Janz, Siegfried
    Barlogie, Bart
    Van Rhee, Frits
    Tricot, Guido
    Shaughnessy Jr, John D.
    Zhan, Fenghuang
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [40] Polyclonal Gamma Globulin Suppression and Risk Of MGUS Progression Into Multiple Myeloma
    Sheqwara, Jawad Z.
    Alhyari, Mohammad
    Keating, Shannon
    Kuriakose, Philip
    BLOOD, 2013, 122 (21)
12345